Dr. Stoller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
3rd Floor
Pittsburgh, PA 15232Phone+1 412-235-1020Fax+1 412-235-1030
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1971 - 1973
Harvard Medical SchoolClass of 1971
Certifications & Licensure
PA State Medical License 1978 - 2022
WV State Medical License 1987 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Start of enrollment: 2006 Oct 23
- ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors Start of enrollment: 2010 May 01
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma Start of enrollment: 2011 Jul 25
Publications & Presentations
PubMed
- A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer...Monica K Malhotra, Shalu Pahuja, Brian F Kiesel, Leonard J Appleman, Fei Ding
Breast Cancer Research and Treatment. 2023-04-01 - 6 citationsA phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovari...Julia Manzo, Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin
Cancer Chemotherapy and Pharmacology. 2022-05-01 - 1 citationsPhase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumorsWilliam F. Maguire, John C. Schmitz, Jonas Scemama, Ken Czambel, Yan Lin
Cancer Chemotherapy and Pharmacology. 2021-06-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
